$70,000 of INCYTE CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Prescription drug payment reform. Pharmaceutical supply chain. General Medicare and Medicaid Issues."
You can find more data on corporate lobbying on Quiver Quantitative.
INCY Insider Trading Activity
INCY insiders have traded $INCY stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $INCY stock by insiders over the last 6 months:
- HERVE HOPPENOT sold 187,500 shares for an estimated $19,773,750
- STEVEN H STEIN (EVP & Chief Medical Officer) has made 0 purchases and 6 sales selling 62,189 shares for an estimated $5,724,777.
- MICHAEL JAMES MORRISSEY (EVP, Head of Tech. Operations) has made 0 purchases and 3 sales selling 58,331 shares for an estimated $5,675,001.
- MOHAMED KHAIRIE ISSA (EVP, Head of US Oncology) sold 10,856 shares for an estimated $1,184,063
- SHEILA A. DENTON (EVP & General Counsel) has made 0 purchases and 11 sales selling 11,119 shares for an estimated $894,765.
- PATRICK A MAYES (EVP & Chief Scientific Officer) has made 0 purchases and 2 sales selling 5,808 shares for an estimated $554,965.
- THOMAS TRAY (Principal Accounting Officer) has made 0 purchases and 2 sales selling 3,374 shares for an estimated $336,350.
- LEE HEESON (EVP, Head of Incyte Intl) sold 3,074 shares for an estimated $289,017
- BARRY P FLANNELLY (EVP & General Manager US) has made 0 purchases and 2 sales selling 2,532 shares for an estimated $174,875.
- VIJAY K IYENGAR (EVP, GMAPPS) has made 0 purchases and 2 sales selling 2,160 shares for an estimated $149,423.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
INCY Hedge Fund Activity
We have seen 389 institutional investors add shares of INCY stock to their portfolio, and 291 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LOS ANGELES CAPITAL MANAGEMENT LLC added 1,447,728 shares (+461.9%) to their portfolio in Q3 2025, for an estimated $122,781,811
- PACER ADVISORS, INC. added 1,233,399 shares (+8091.6%) to their portfolio in Q3 2025, for an estimated $104,604,569
- MARSHALL WACE, LLP removed 1,195,191 shares (-98.7%) from their portfolio in Q3 2025, for an estimated $101,364,148
- CAISSE DE DEPOT ET PLACEMENT DU QUEBEC added 1,087,091 shares (+264.5%) to their portfolio in Q3 2025, for an estimated $92,196,187
- ROYAL BANK OF CANADA added 1,058,178 shares (+247.5%) to their portfolio in Q3 2025, for an estimated $89,744,076
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,036,518 shares (+52.6%) to their portfolio in Q3 2025, for an estimated $87,907,091
- DODGE & COX removed 662,765 shares (-4.5%) from their portfolio in Q3 2025, for an estimated $56,209,099
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INCY Analyst Ratings
Wall Street analysts have issued reports on $INCY in the last several months. We have seen 7 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 11/24/2025
- Piper Sandler issued a "Overweight" rating on 11/04/2025
- Guggenheim issued a "Buy" rating on 11/03/2025
- Wells Fargo issued a "Overweight" rating on 10/29/2025
- Stifel issued a "Buy" rating on 09/22/2025
- B of A Securities issued a "Buy" rating on 09/04/2025
- BMO Capital issued a "Underperform" rating on 07/30/2025
To track analyst ratings and price targets for INCY, check out Quiver Quantitative's $INCY forecast page.
INCY Price Targets
Multiple analysts have issued price targets for $INCY recently. We have seen 16 analysts offer price targets for $INCY in the last 6 months, with a median target of $101.5.
Here are some recent targets:
- Vikram Purohit from Morgan Stanley set a target price of $94.0 on 01/06/2026
- Salim Syed from Mizuho set a target price of $121.0 on 12/08/2025
- Derek Archila from Wells Fargo set a target price of $116.0 on 12/08/2025
- Etzer Darout from Barclays set a target price of $115.0 on 11/24/2025
- Allison Bratzel from Piper Sandler set a target price of $102.0 on 11/04/2025
- Michael Schmidt from Guggenheim set a target price of $125.0 on 11/03/2025
- Brian Abrahams from RBC Capital set a target price of $84.0 on 10/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
